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Abstract: Traditional in vivo devices fabricated to be used as implantation devices included
sutures, plates, pins, screws, and joint replacement implants. Also, akin to developments in
regenerative medicine and drug delivery, there has been the pursuit of less conventional in vivo
devices that demand complex architecture and composition, such as tissue scaffolds. Com-
mercial means of fabricating traditional devices include machining and moulding processes.
Such manufacturing techniques impose considerable lead times and geometrical limitations,
and restrict the economic production of customized products. Attempts at the production of
non-conventional devices have included particulate leaching, solvent casting, and phase trans-
ition. These techniques cannot provide the desired total control over internal architecture and
compositional variation, which subsequently restricts the application of these products. Con-
sequently, several parties are investigating the use of freeform layer manufacturing techniques
to overcome these difficulties and provide viable in vivo devices of greater functionality. This
paper identifies the concepts of rapidmanufacturing (RM) and the development of biomanufac-
turing based on layer manufacturing techniques. Particular emphasis is placed on the develop-
ment and experimentation of new materials for bio-RM, production techniques based on the
layer manufacturing concept, and computer modelling of in vivo devices for RM techniques.
Keywords: rapid manufacturing, drug delivery devices, implants, scaffolds, in vivo devices
1 INTRODUCTION of donors, limited amount of surplus tissue, high
rejection potential, and complications as a result
of donor site morbidity, patient distress, potential ofIn vivo devices are artificial devices put into the
human body or living organisms to replace or restore transmission of infectious diseases, reduced speed
of treatment and quality of life, and increased lifefunctions of living tissues [1]. The manufacture of in
vivo devices for bone replacement was conceived in expectancy have led to thousands of patients spend-
ing the rest of their lives before they receive an organthe 1950s by Sir John Charnley [2]. The concept of
implantation devices was partly invoked by the from a suitable donor [3–7]. Approximately one-
quarter of patients in need of organ transplants inrestrictions of restoration by transplantation. Auto-
grafting (transplantation of surplus tissue, typically the United States die while waiting for a suitable
donor [8]. Such figures and patient distress and poorbone, from one location to another in the same
patient) and allografting (transplantation of a tissue quality of life have further driven the continued
investigation of synthetic or artificial replacements.or organ from a donor to the patient, typically the
The construction and composition of implantkidney or heart) both require additional procedures
devices for tissue replacement or regeneration areand incur higher cost and risk of infection/transfer
dictated by the requirements of their application, i.e.of disease, and they are fundamentally limited by the
relatively solid products for bone replacement oramount of surplus tissue in the desired morphology
deliberately porous structures for tissue growthor the shortage of donors. An increase in the shortage
scaffolds, but also by the restrictions of their pro-
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Table 1 Biomaterial examples [9, 16–18]a largely laboratory-based activity that begins with
living tissue cells which are multiplied through cell
Material type Biomaterials
culture. These are then seeded into a carrier/scaffold
Ceramic Hydroxyapatite (HA)which facilitates the directed three-dimensional
Oxyfluorapatite and wollastonite glassy matrixgrowth and proliferation. This form of regenerative (A–W glass)
Tricalcium phosphate (TCP)medicine may provide replacement tissue and
Alumina (Al
2
O
3
)organs and is widely foreseen as one of the next great
Zirconia (ZrO
2
)
breakthroughs in medical treatment. Subsequently, Carbon
there is significant competition to formulate and Metal Pure titanium and alloys (Ti)
Grade 300 stainless steel (mainly 316 and 316L)exploit a suitable three-dimensional containment
(AISI classification)structure to facilitate the growth of tissue-engineered
Cobalt–chromium
in vivo devices. Dental amalgam
Shape memory alloys (SMA)
Polymers Ultrahigh molecular weight polyethylene
(UHMWPE)2 BACKGROUND
High-density polyethylene (HDPE)
Polyethylene (PE)
Polyurethane (PU)2.1 Biomaterials
Polytetrafluoroethylene (PTFE)
Polyamides (PA)In vivo devices are fabricated using materials of
Polyesternatural or man-made origin and are used to direct,
Polydimethyl silicones (PDS)
supplement, or replace the functions of living tissues Polymethyl methacrylate (PMMA)
Polyethylene terepthalate (PET)of the human body [9]. Over the years the impor-
Silicone rubber (SR)
tance of avoiding risk, rejection, or complications in Polysulphone (PSU)
Poly(vinyl chloride) (PVC)the body [9–13] has been highlighted because these
Polyther ether ketone (PEEK)may hinder normal development and physiological
Poly(lactic acid) (PLA)
behaviour of cells, result in secondary infections, and Poly(glycolic acid) (PGA)
Poly(e-caprolactone) (PCL)inhibit the function of devices. Fundamental require-
Polyhydroxybutyrate (PHB)ments of an implant device include biocompatibility Hydrogels
and surface and structural compatibility. Poly(lactide-co-glycolide) (PLGA)
Poly(l-lactic acid) (PLLA)Biocompatibility is a descriptive term of the ability
Poly(d-lactic acid) (PGLA)
of a material to perform with an appropriate tissue
response, in a specific condition. This is a most criti-
cal characteristic and precludes all other selection physical, and mechanical properties. These proper-
criteria. To achieve the required biocompatibility, ties are not only determined by the inherent material
two routes are often employed: properties but also by the implant design and its
internal architecture [19–21].(a) the fabrication of in vivo devices using off-the-
shelf materials with application of a suitable
2.2 Types of in vivo devicebiocompatible coating layer;
(b) the fabrication of in vivo devices using biocom- Increased life expectancy and greater healthcare
patible materials. capabilities has led to the development of a large
number and diverse range of in vivo devices.This section only discusses the latter. The materials
Currently, in vivo devices such as pins, plates, rods,used to fabricate in vivo devices may be grouped into
screws, drug delivery devices, valves, sutures, grafts,metals, ceramics, polymers, and composites thereof.
and fixations are produced to assist in the treatmentBiomaterials have been further classified on the basis
and recuperation of patients for a variety of con-of their function, such as bioinert, bioactive, bio-
ditions. Subsequently, in vivo devices serve a varietystable, and biodegradable [14, 15]. No one material
of functions. These may include the replacement ofis suitable for all biomaterial applications. Advan-
a damaged tissue or organ, provision of temporarytages and limitations of each individual material and
or permanent mechanical support, and the con-the suitability of materials for specific applications
trolled release of drugs in relation to the individualhave been studied through laboratory experiment-
patient and treatment. An ideal would be for oneation and clinical investigations [16]. Table 1 lists a
device to serve a combination of functions, e.g. avariety of commonly used biomaterials.
bone replacement implant would provide comple-The surface and structural compatibility of a mate-
rial refers to the suitability of its chemical, biological, mentary geometry according to the bone defect site,
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a Young’s modulus nearly equal to the local bone, of fixation components, the indirect manufacture of
surgical guides and templates [41], fit evaluation ofselective designed porosity to facilitate growth of
tissue into the device, and osteogenic stem cell deliv- implants [42, 43], and as an enabling process in facial
prosthetics [44]. Some of the benefits (i.e. increasedery for faster integration of surrounding tissue. Such
ideals would place great demands on manufacturing speed, customization, and efficiency) that have been
realized through this work have prompted continuedprocess technology.
To date, conventional in vivo device fabrication research and further applications of layer manufac-
turing technologies, leading to the investigation oftechniques have included compression/injection/
melt moulding [22–24], fibre bonding [25, 26], phase their use for the direct production of medical devices.
RM is the use of layer manufacturing processes toseparation [3, 5, 11], solvent casting/particulate
leaching [3, 27, 28], membrane lamination [26], deliver finished parts directly from digital data. The
concept of RM offers a compelling list of benefits.gas foaming/high-pressure processing [29], the lost
mould method [30], emulsion freeze drying [31], and With RM, tooling is eliminated, thus substantially
reducing time and cost. There are other powerfulcombinations of these techniques [32] and machin-
ing techniques. advantages that result from the tool-less process,
including increased design freedom, heterogeneousWith particular regard to scaffold structures, sev-
eral production methods are capable of fabricating materials, custom products, just-in-time production,
and decentralization of production [45].foam structures. However, to date these processes
have been unable to achieve all the desired charac- In particular reference to in vivo devices, the
potential advantages include the following.teristics of an optimum scaffold design – precisely
controlled variation of external geometry, pore size,
1. Fewer design constraints. RM greatly reduces thepore geometry, spatial pore distribution, pore inter-
number of design constraints that are typicallyconnectivity, and construction of internal channels
imposed by many manufacturing processes. Thiswhich govern interactions between cells. An example
is a result of the freeform nature of RM as com-of the effort of these restrictions is provided by
pared with conventional techniques which rely onSachlos and Czernuszka [33]: the growth of bone
tooling for their fabrication process and com-tissue is limited to the external surface (less than
monly limit the ability to achieve complex geo-500 mm in depth) owing to the diffusion constraints
metries and inhibit the production of internal(i.e. interconnectivity, pore size, etc.) of the foam
features [46, 47].constructed using conventional techniques includ-
2. Customization. The tool-less and direct nature ofing fibre bonding, solvent casting/particulate leach-
RM allows the economic production of one-offing, etc.
articles. This enables product customization while
sustaining economic viability as compared with
2.3 Rapid manufacturing traditional techniques which must manufacture
on mass in order to obtain economic viability.Rapid manufacturing (RM) is the direct production
This would offer the potential to provide in vivoof finished goods from a layer manufacturing device,
devices designed in response to specific customerknown commonly as rapid prototyping (RP). Various
requirements.RP techniques exist which utilize several different
3. Greater speed from image capture to finishedprocessing fundamentals, but they all share the
device. Direct device production by RM has rela-characteristic of producing an object by a sequential
tively few process steps and subsequently a shortlayer manufacturing technique. RP processes directly
lead time. RM is able to manufacture the parts inproduce a physical geometry from data derived
hours and days, as opposed to weeks and monthsfrom a three-dimensional representation (i.e. three-
for tooling processes, as a result of the streamlineddimensional CAD), and they are characterized by
process, automation, and little manual inter-generation of the geometry by an additive, layer-by-
action [48].layer manufacturing sequence, which, when in-
4. Functionally graded materials (FGMs). An FGMitiated, runs unattended [34]. Further reference to RP
can be defined as a material exhibiting spatiallyand particular processes can be found elsewhere
inhomogeneous properties and microstructure.[35].
This is a possibility in RM methods by varying theRP has largely been used to date in the medical
composition of two or more materials across thefield for producing models for visualization and
surface, interface, or bulk of the product duringevaluation. RP applications have included preoperat-
ive planning and simulation [36–40], preforming the build sequence. An FGM allows for the
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positional variation of physical properties and 3 SPECIFIC ADVANCES IN MODELLING AND
characteristics. Potential applications of FGMs in DESIGN
implant devices are illustrated in Fig. 1.
5. Processing without toxic solvents. Several RM tech- Computer aided design (CAD) anatomical models
niques operate without the use of solvents as are most commonly derived by reverse engineering,
employed by some conventional techniques (e.g. typically by computed tomography (CT) and/or mag-
particulate leaching, hydrocarbon templating, netic resonance imaging (MRI) techniques [51, 52].
etc.). Incomplete removal of solvents may result CAD data are a primary process in RM and sub-
in harmful residues that have adverse effects on sequently the full exploitation of RM as a production
adherent cells, incorporated biological active method for in vivo devices is also dependent upon
agents, or nearby tissues. synchronous developments in associated design
6. Controllable structure and porosity. The freeform software. Various research groups have used CAD
fabrication technique utilized by RM allows for systems to conduct simulated predictive analysis
the production of virtually unrestricted geo- prior to production [53]. Although some of the CAD
metries. Owing to the additive nature of the pro- developments being investigated by various research
cess, control over internal structure is possible. groups are not necessarily solely aimed at the direct
This would allow the internal structure and manufacture of in vivo devices, with some adap-
porosity to be controlled and dictated. Implant tation it may be feasible to adopt some of these tech-
applications may include selective areas of niques for the design of in vivo devices. However, it
greater/lesser structural integrity and selective should be noted that there are ongoing discussions
areas of encouraged blood flow. Absolute dictation regarding the amount of current potential appli-
of geometrical structure would allow highly cations for custom prosthesis. Several cases are sum-
complex customized tissue scaffolds to be pro- marized below.
duced. Bibb [54] reported the production of physical
stereolithography (SLA, an RP technique based onConventional RP processes and materials were
the selective curing of a photosensitive resin) modelsdeveloped in response to the desire of several indus-
of cancellous bone structures (see Fig. 2). The struc-tries to be able quickly and automatically to produce
ture could be controlled using commercial voxel-representative or functional prototypes of objects
based CAD software. Emphasis was placed on thethat would later be manufactured in large quantities
ability of RP to generate controlled structures andby tooling processes [50]. The interest from themedi-
the impossibility of using any other approach.cal field has grown recently, which, after very positive
Werner et al. [55] reported the use of CAD systemsresults, has subsequently resulted in various investi-
to help design anatomical hip joint endoprosthesisgations and research into the RM of in vivo products.
by applying the non-uniform rational B-splineThe following sections present details on the research
(NURBS) technique in describing curves and sur-efforts to date in the fabrication of in vivo devices
using RM techniques. faces. The redesigned endoprosthesis aimed to
Fig. 1 Example of FGM application [49]
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constructed/reconstructed models manufacturable.
Subsequently, two areas of future work were recom-
mended:
(a) the ability to establish a relationship between a
NURBS volume and its corresponding volume
model to gain structural information that would
make it easier to manipulate and control a
volume;
(b) solving the problem of long computational time
and large files generated by the marching cubes
algorithm (an algorithm used to generate an STL
file from volume models).
4 RM PROCESS TECHNOLOGIES FOR IN VIVO
DEVICES
A number of research groups have investigated the
utilization of layer manufacturing in the develop-
ment and production of in vivo devices, including
scaffolds, pins, screws, drug delivery devices, and
Fig. 2 Cancellous bond (STL file image) [22] valves. Many of these are indirect techniques where
layer manufacturing is an enabling process and con-
stitutes only part of a multiprocess chain, and do
provide greater stability and minimize loosening of
not fully exploit the potential of RM. Such indirect
the implant.
examples include: tissue scaffolds for heart valves
Zysset et al. [56] demonstrated the use of CAD for
by Sodian et al. [59], biodegradable scaffolds using
predictive mechanical analysis of modelled bone
SLA by Levy et al. [60], hydroxyapatite implants by
structures. The trabecular bone structure from the
Chu et al. [19], hydroxyapatite scaffolds using the
human proximal femur was modelled to investigate
ModelMaker II RP system [61], and biomimetic
its mechanical integrity for managing issues such as
and composite three-dimensional polymer–ceramic
osteoporosis or implant fixation. Mechanical tests of
scaffolds using three-dimensional printing (3DP)
scaled physical models [fused deposition modelling
(see section 4.3 for a short definition) [62].
(FDM, an RP technique based on the extrusion of a
In recent years there has been increasing emphasis
semi-molten plastic filament) and stereolithography
placed on the research of RM for the direct pro-
(SLA)] correlated with the results of a digital finite
duction of in vivo devices. Several parties have
element analysis conducted through CAD.
investigated the adaptation of existing commer-
Current CAD systems are geared towards the
cialized RP processes for producing in vivo devices,
design of parts manufactured by traditional manu-
as described in the following subsections according
facturing technologies and hence represent a solid
to process types.
object by its surface [57]. Researchers at the Nanyang
Technological University have taken a step forward
4.1 Stereolithography for in vivo devices
in exploring a new approach to modelling complex
objects. This is based on NURBS-based volume mod- Stereolithography is an RP technique based on the
selective curing of a photosensitive polymer resin.elling which not only represents the surface bound-
ary but also the interior of a three-dimensional SLA is the most developed commercial RP process,
its development began in the early 1980s, and it isobject. The key idea of the NURBS-based volume
modelling is to exploit the flexibility of NURBS mod- capable of high degrees of accuracy (±0.005 XY,
±0.002 Z ). However, traditional SLA materials con-elling and use the voxelized NURBS volumes as
components for constructing complex objects, in tain toxic components that prohibit their application
for in vivo use. Commercial SLA materials thatparticular with respect to medical applications [57,
58]. Valid STL file (the input format required by may be used in limited bodily fluid exposure have
emerged, but there is none for in vivo use. Sub-most RP processes) generation through volume
modelling and isosurface extraction makes the sequently, applications for implant production have
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been restricted to indirect techniques. Some note- 3.6 MPa, yield strain 4–28 per cent). The highest
compressive stiffness and yield strength were foundworthy investigations on the development of bio-
materials for SLA have been conducted by Matsuda in specimens built with a combination of 0/90° lay-
down orientation and a porosity of 53 per cent, whichand Mizutani [63, 64], and the feasibility of SLA to
build and control three-dimensional multilayer parts lie in the lower range of properties reported for tra-
becular bone.made from biodegradable, biocompatible resin poly-
propylene fumarate has been demonstrated by Too et al. [69] investigated the development and
feasibility of three-dimensional non-random porousCooke et al. [65].
structures (i.e. scaffolds) using FDM for various
applications in tissue engineering. Acrylonitrile–
4.2 Fused deposition modelling for in vivo
butadiene–styrene (ABS) test specimens were gener-
devices
ated using a road width (distance between consecu-
tive filaments) of 0.315 mm, a slice thickness ofFused deposition modelling is an RP technique
based on the extrusion of a semi-molten plastic 0.254 mm, and a varied raster gap of 0–0.5 mm in
increments of 0.05 mm. Micrographs indicated thatfilament. It is an uncomplicated and reliable process
and has been the subject of several investigations three-dimensional interconnecting pore structures
existed within specimens. It was noted that the rasterregarding use with different biocompatible materials.
The porosity of FDM parts is easily altered according gap settings had a major influence on the micro-
structure of the specimens. Porosity values rangedto the raster pattern utilized, but functionally graded
material (FGM) applications are inherently limited between 22 and 68 per cent, while compressive
strength values ranged between 5 and 20 MPa.by the material format (filament).
Kalita et al. [66] investigated the development and
fabrication of controlled-porosity structures using
4.3 Three-dimensional printing for in vivo
polypropylene (PP) polymer and tricalcium phos-
devices
phate (TCP) ceramic, employing FDM for the healthy
ingrowth of bone cells. Samples with 36 per cent Three-dimensional printing (3DP) is an RP process
operating by the selective deposition of a bindingvolume porosity and an average pore size of 160 mm
showed the best compressive strength of 12.7 MPa, liquid onto a powdered material to form a solid
mass [70]. The 3DP process was developed at thewhich lies in the lower range of properties reported
for trabecular bone. The results showed that samples Massachusetts Institute of Technology and has sub-
sequently been licensed to machine producers [52,were non-toxic and also supported excellent cell
attachment and growth during the first 2 weeks of in 71, 72]. This process has been subject to consider-
able investigations for RM, in particular for scaffoldsvitro (simulation of conditions inside a living organ-
ism) studies. and drug delivery applications [73, 74]. The process
has the potential to incorporate different materialHutmacher [67] reported the fabrication of bone
scaffolds for complex craniofacial skeletal recon- options owing to the flexibility of the material format
(liquid and powder). The material format may alsostruction utilizing medical imaging, computational
modelling, and FDM. The study indicated that the facilitate the possibility of functionally graded mate-
rials (FGMs), but may also be the source of difficult-use of polycaprolactone (PCL) scaffolds produced by
FDM for the reconstruction of craniofacial defects ies for complex internal structures owing to powder
entrapment.resulted in higher amounts of new bone ingrowth
than clinically used poly(l-lactic acid)/poly(d-lactic Lam et al. [75] investigated the development of
scaffolds using 3DP. A blend of starch-based polymeracid) (PLLA/PDLA) 70/30 foil. Results indicated that
scaffolds coated with bone marrow resulted in higher powders (50 per cent cornstarch, 30 per cent dextran,
and 20 per cent gelatin) was developed for use inbone formation.
Zein et al. [68] investigated the effect of process various tissue engineering applications. The scaffolds
were built and characterized for several properties,variation in the fabrication of PCL porous scaffolds
using FDM for an intended application in bone tissue including porosity, compression, and water absorp-
tion, using scanning electron microscopy (SEM) andengineering. Various processing parameters were
used to fabricate scaffolds with a channel size of differential scanning calorimetry (DSC). Five differ-
ent designs were fabricated and post-processed160–700 mm and a porosity of 48–77 per cent. A great
variation in mechanical properties was demon- by infiltrating scaffolds with different amounts of
copolymer solution, with half of them being soakedstrated in accordance with varied porosity (com-
pressive stiffness 4–77 MPa, yield strength 0.4– in deionized water for 10 min and dried to enhance
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the mechanical and chemical properties. As a result Tan et al. [82] investigated the use of a polyether
of the post-processing employed, the shrinkage ether ketone (PEEK) and hydroxyapatite (HA) com-
ranged between 2 and 12 per cent depending on the posite with different percentage composition ratios
design. Microporosity values decreased after infil- using a commercial SLS machine for the intended
tration because the copolymer infiltrated the micro- application of scaffold-guided tissue engineering.
pores and voids. A linear and inversely proportional The laser power, part bed temperature, and scan
relationship between compressive stiffness and speed were the three SLS parameters investigated.
porosity was found. Results indicated that 40%HA was an ideal com-
Other research work has investigated the use of position to produce structures with good integrity.
three-dimensional printing for the fabrication of cus- Optimum SLS processing occurred at a low part bed
tomized polymeric drug delivery systems to over- temperature complemented by a higher laser power.
come the drawback of decreased drug release rate as Further studies [83] have been conducted with vari-
a function of time. A drug concentration profile is ous biodegradable polymers including polycapro-
generated in a computer model, which is produced lactone (PCL) and Poly(l-lactic acid) (PLLA) for
by 3DP. By this means, complex drug delivery regimes applications where anchorage-dependent cells rely
can create multiple drugs or the multiphase release on the use of temporary three-dimensional scaffolds
of a single drug. to guide cell proliferation. This study has ascertained
the possibility of using biocompatible polymers in
4.4 Selective laser sintering for in vivo devices SLS. The technique enables the production of the
well-defined pore interconnectivity required bySelective laser sintering (SLS) is a commercialized RP
tissue engineering, which gives SLS the edge overtechnique that operates by the selective melting and
conventional manual-based fabrication techniques.fusion of a powdered material by laser exposure. SLS
Das et al. [84, 85] investigated the use of SLS withwas developed in the late 1980s at the Mechanical
nylon-6 to fabricate scaffolds with periodic andEngineering Department of the University of Texas
biomimetic internal architecture which had beenat Austin [35, 76, 77]. The process has a relatively
produced by computational design methods withlarge range of materials that may be processed, but
intended application for hard tissue engineeringequipment and ancillary costs are high.
scaffolds. In vitro results indicated that 51–65 perPioneering work by Lee and Barlow [78, 79] on
cent of the pore space was occupied by the regener-polymer-coated calcium phosphate for the fabri-
ated bone, which is consistent with monolithiccation of artificial bone implants first revealed the
hydroxyapatite scaffolds. The level of cell viabilitypotential capabilities of employing SLS for in vivo
was less than 70 per cent on average. Studies havedevices.
also indicated the possibility of constructing func-Improvements in the SLS process are expected and
tionally tailored tissue scaffolds in a single step viaare being researched to enable RM to be used for the
SLS of multiple materials, which would enable theproduction of desired scaffolds for tissue engineer-
simultaneous growth of multiple tissues, tissueing. These include developing the ability to create
interfaces, and blood vessels.smaller features by using a smaller laser spot size,
Chua et al. [86, 87] reported the fabrication ofpowder size, and thinner layer thickness [80].
poly(vinyl alcohol) (PVA) and hydroxyapatite (HA)Cruz and Simoes [46] reported the production of
composites by SLS to fabricate three-dimensionalpoly(l-lactide)/hydroxyapatite composite (PLLA/HA)
tissue engineering scaffold structures. The PVA/HAimplants for lower load bearing applications using
powder showed promising sintering results. Simu-SLS. Authors have emphasized that the production
lated body fluid (SBF), which has an ionic concen-of implants using RM technologies is still at an
tration and pH almost equal to those of human bloodembryonic stage and far from the industrial pro-
plasma, was used to analyse chemical and morpho-duction stage.
logical changes of HA in the test specimens by imitat-Rimell and Marquis [81] reported the investigation
ing actual physiological interaction between the HAof SLS using ultrahigh molecular weight polyethyl-
surface and the implant site. Bioactivity analysis indi-ene (UHMWPE) for clinical applications including
cated the presence of hydroxycarbonate apatitepatient-tailored prostheses. This study raised a
(HCA) on specimens soaked in SBF.number of concerns, including material shrinkage,
Goodridge et al. [88] reported a study of the directthe porosity formed, degradation in terms of chain
SLS of both apatite–mullite glass ceramic andscission, crosslinking, and oxidation. It was con-
hydroxyapatite (HA) with lower-melting calciumcluded that the development of new powders with
increased density was required. sodium phosphate (CNP – resorbable glass) for bone
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replacement implants. Success with the glass cer- cations with varying degrees of success. Most of these
processes possess different limitations that deriveamic was observed with a powder size range between
0–45 mm and 45–90 mm. HA-CNP was sintered into from their development for use as models/prototype
production processes and not as dedicated manufac-10 mm×10 mm×5 mm blocks by direct SLS. How-
ever, no success was achieved in producing samples turing technologies for the RM of specific in vivo
devices. Along with those discussed in the previousof similar strength to typical bone.
Savalani and Harris [49] studied the effect of vary- sections, other limitations include the following.
ing particle size of a commercial hydroxyapatite-
1. Among the greatest restrictions are the currentreinforced polyethylene (HA–HDPE) bioactive poly-
material limitations – very few biocompatible ormer/ceramic composite material for the direct pro-
bioactive materials are currently available thatduction of bioactive implants and tissue scaffold
have undergone the necessary development forstructures using selective laser sintering. It was found
regulatory use. The majority of RP/RM materialsthat particles within 100 mm fused irrespective of the
developed and introduced to date have beenparticle morphology. Further studies [89] illustrated
largely based upon improvements in mechanicalthe effects on the degree of sintering of HAPEXA of
integrity.a varying laser power and scan speed. Preforms fabri-
2. Several current processes rely on high tempera-cated at various power and speed settings resulted
tures during and after manufacture. Heating toin a porous or relatively dense morphology.
elevated temperatures influences the integrity ofChua et al. [90] reported the production of scaffold
several biomaterials, some even beyond bodystructures with consistent and reproducible microar-
temperature levels.chitectures by using a scaffold library algorithm
3. Little attention has been paid to the RM of steriletogether with SLS for various tissue engineering
products, either in terms of their manufacturescaffolds. The scaffolds were not built with a biomat-
(clean room compatible processes) or in termserial but with commercial SLS nylon (DuraformTM),
of the ability of materials to withstand post-since this particular research focused largely on
manufacture sterilization processes.assessing the design possibilities. Pore sizes of
4. Paramount to the full exploitation of RM for inbetween 0.616 and 0.905 mm were fabricated. How-
vivo devices is the integration of complex internalever, removing the loose powder within the pores
structures and variable composition. There haveproved to be difficult.
been several developments regarding the inte-Williams et al. [91] experimented with the SLS of
gration of such capabilities in the production pro-polycaprolactone (PCL), which is bioresorbable, with
cess, but there have been relatively few relatedpotential applications for bone and cartilage repair.
developments in the design capabilities for this.Scaffold designs were produced by computational
Three-dimensional CAD is a primary enablingmethods, and porous PCL structures were fabricated
technology in RM, and there has been littleusing SLS. The compressive modulus and yield
advance in capabilities for internal design, bothstrength values ranged from 52 to 67 MPa and from
geometrical and compositional, through CAD2.0 to 3.2 MPa respectively, lying within the lower
software.range of properties reported for human trabecular
5. Removal of powders – powder-based techniquesbone. It was concluded that the integration of com-
(e.g. SLS and 3DP) require post-processing tech-putational scaffold design and layer manufacturing
niques to enable the removal of trapped powder.techniques could prove highly useful for the con-
This process may be a limiting factor of thestruction of scaffolds that have anatomy-specific
internal architecture that can be produced. More-exterior architecture derived from patient CT or MRI
over, it may also result in reduced biocompati-data and an interior porous architecture derived
bility of in vivo devices owing to the mediafrom computational design optimization.
containing leach-out products which result in det-Other research work conducted by Nanyang
rimental cellular response and, in turn, reducedTechnological University Singapore for healthcare
cell viability.applications leans towards the production of drug
delivery devices [92–96].
5 NOVEL RM TECHNOLOGIES
4.5 Limitations of traditional RP/RM processes
Some of the established commercial RP processes The investigation of novel RM technologies for in
vivo devices has been prompted by the limitationshave been investigated for the RM of in vivo appli-
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Fig. 3 Bioplotter process schematic (adapted from reference [99])
of conventional RP and RM techniques that have Mironov et al. [102] reported the concept, practical
aspects, and development of an RM cell printer forbeen used in other applications for modelling,
reverse engineering, etc. Novel techniques developed direct soft tissue engineering. The cell printer aims
to overcome the limitation of RP techniques, whichby various research groups include the following.
The Bioplotter, invented at the Freiburg Materials are not capable of precisely placing cells aggregated
into a printed scaffold. The process involves threeResearch Centre and developed by Envisiontech
GmbH, is a commercially available system that incor- sequential steps: preprocessing or development of
blueprints for organs; processing or actual organporates cultures of the patient’s own cells to build
scaffold structures (see Fig. 3). The principle of the printing; and post-processing or organ conditioning
and accelerated organ maturation. Cell or cell aggre-process involves a plotting material (with cells) being
dispensed through a nozzle by air-pressure control gates are placed in a three-dimensional gel with
sequential maturation of the three-dimensionalinto a bath of liquid with matching density and
polarities, thus preventing gravity-induced structural organs using a thermoreversible gel or matrix that
solidifies upon fusion. Thus far, a cell printer hascollapse [97–99]. This technique has been used by
Landers et al. [100] who reported the building of been developed that could fuse closely placed cell
aggregates and heart mesenchymal (cushion tissue)scaffolds derived from thermoreversible hydrogels (a
polymer network with high water content) for soft fragments into ring and tube-like structures in three-
dimensional gel (see Fig. 4).tissue engineering. This work produced hydrogel
scaffolds with a specific external shape and a defined Xiong et al. [103, 104] reported the fabrication of
porous poly(l-lactic acid) (PLLA) scaffolds using aninternal pore structure. The geometry of a nose was
fabricated to demonstrate the potential for soft tissue RM technique termed precise extrusion manufactur-
ing (PEM). This extrusion-based system feeds aimplant generation. Further studies have indicated
the need for more basic research to improve the per- heated thermoplastic material onto a working plat-
form using a special sprayer extruder for preciseformance of hydrogel scaffolds in tissue engineer-
ing [101]. extrusion. The extruder is designed with compressed
Fig. 4 Cell printer process [89]
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air and a tie-in as opposed to the driving wheels used (MDM) system [104, 107, 108], has been investigated
for the fabrication of bone tissue engineeringin a commercial FDM machine. The extruder is con-
trolled using software that will not scan the contour scaffolds with gradient materials and morphologies.
Further investigations have led to the possibility ofbut only scan the filling-in network of the object,
which ensures an open porous architecture of the extruding poly(e-caprolactone) (PCL) for the free-
form construction of three-dimensional tissue scaf-scaffolds. The process builds physical objects in a
layer-by-layer fashion directly driven by three- folds at room temperature and low pressures [12].
Wang et al. [109] reported the fabrication of cellu-dimensional CAD data. The scaffolds exhibited con-
trolled porous architectures of 200–500 mm. It is lar PCL scaffolds using a novel precision extruding
deposition (PED) technique which involves a mini-made clear that the design of scaffold material and
the modelling techniques of porous scaffolds are extruder system delivering the PCL in a fused form
through the deposition nozzle. The major differencepivotal questions. Further studies on degradation
evaluation in vitro showed that a 90 per cent mass between the PED process and the conventional FDM
process is that the scaffolding material can beloss was experienced after samples were immersed
in pancrelipase phosphate buffer saline (PBS) for 2 directly deposited through the PED process without
involving filament preparation. Scaffolds with a con-weeks. Based on the enzyme activity, it was estimated
that those PLLA scaffolds would degrade almost trolled pore size of 250 mm and designed structural
orientations were fabricated. Further work has beenwholly within 100 days in vivo, which was considered
appropriate for the bone repair process. conducted by Darling and Sun [110] to characterize
the microstructure of scaffolds made using PED.Xiong et al. [104, 105]reported the fabrication of
poly(l-lactic acid)/tricalcium phosphate (PLA–TCP) The micro-CT imaged pores were between 200 and
300 mm, the optimal size suggested for tissue scaf-scaffolds for tissue engineering using a technique
termed low-temperature deposition manufacturing folds. The greatest asset of samples manufactured by
this technique is the possibility of obtaining porous(LDM) (see Fig. 5). LDM is based on a droplet
assembly process that may maintain the bioactivity interconnectivity greater than 98 per cent.
Ciardelli et al. [111] investigated the testing andof scaffold materials because of its non-heating
liquefying process compared with RP technologies fabrication of poly(e-caprolactone) (PCL) and poly(e-
caprolactone)–poly(oxyethylene)–poly(e-caprolac-such as SLA, SLS, and FDM which work at high tem-
peratures. A composite of PLA and TCP was used to tone) (PCL–POE–PCL) scaffolds using a pressure-
assisted microsyringe (PAM) technique and SLS.form a bone scaffold. These scaffolds possessed a
high porosity level of 90 per cent with controlled Scaffolds were successfully produced using these two
means of fabrication. Emphasis was placed on theinterconnectivity and macrocellular and microcellu-
lar morphology while retaining mechanical property substantially different structure resolution achiev-
able in the two processes, as PAM allows the fabri-values close to human spongy bones. In vivo results
showed good bone conductivity and appropriate cation of fine-featured microstructures down to
5-10 mm wide and 5 mm high, whereas SLS structuresbiodegradation property for bone repair. Concurrent
studies with regard to the PLA degradation rate are demonstrated a resolution of about 300 mm height
×700 mm width.being carried out by several researchers including
Kim et al. [106]. Vozzi et al. [112] reported the fabrication of
poly(d,l-lactide-co-glycolide) (PLGA) scaffolds withAn extension of the LDM process, namely the mul-
tinozzle (four-nozzle) deposition manufacturing a feature size of approximately 10–30 mm using a
Fig. 5 Low-temperature deposition manufacturing process [105]
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pressure-assisted microsyringe (PAM). PAM is based for porous bone grafts using robocasting. Robo-
casting is an additive freeform fabrication techniqueon the use of a microsyringe that utilizes a computer-
that robotically deposits ceramic suspensions for thecontrolled, three-axis micropositioner, which allows
fabrication of HA structures with controlled internalthe control of motor speeds and position. A PLGA
architectures. Structures with controlled pores in thesolution is deposited from the glass capillary needle
size range from 100 mm to 1 mm have been pro-of a syringe by the application of a constant pressure,
duced.resulting in a controlled polymer deposition. Prior
attempts to manufacture scaffolds using microsyr-
inge techniques have achieved resolutions of 50 mm
6 BIOMATERIALS FOR RM TECHNIQUES[113]. The adapted PAM technique enables a reso-
lution of 10 mm in the horizontal direction and
For the development of novel RM techniques for in5–10 mm in the vertical direction. Although this
vivo devices, it is essential that it be accompaniedsystem is highly automated and provides the pos-
with appropriate material development. A relativelysibility of dynamically altering polymer composition,
small amount of research has been conducted in thea limited number of materials can be used owing to
field of biomaterials for RM.the narrow range of viscosities that can be employed
Tian et al. [117] demonstrated the preparation andto obtain high-resolution structures.
characterization of HA suspensions by wet chemicalAng et al. [114] reported the fabrication of three-
synthesis for layer manufacturing in 2002.dimensional chitosan (a naturally occurring amino-
Pfister et al. [118] reported the development andpolysaccharide) and HA (0, 20, and 40%HA) scaffolds
use of zinc polycarboxylate ionomers as a powderwith regular and reproducible macropore architec-
material for 3DP. These ionomers demonstratedture using a robotic dispensing system. The system
stiffness and water-resistant properties withoutwas an extrusion-based system consisting of a com-
requiring post-printing treatments.puter-guided desktop robot and a single-component
The Bioplotter technology allows the incorporationpneumatic dispenser. In vitro cell culture studies
of natural materials including aqueous solution and
indicated that the scaffolds were capable of cell seed-
pastes. However, the key feature of this technology
ing and strong proliferation throughout the culture
is the three-dimensional dispensing of liquids and
period.
pastes onto a plotting medium with similar density
Woodfield et al. [115] reported the production
to compensate for gravity forces through buoyancy
of three-dimensional biodegradable poly(ethylene
[99, 100]. As a consequence, complex structures
glycol)terephthalate–poly(butylene terephthalate)
may be produced without requiring the construction
(PEGT/PBT) block copolymer scaffolds with a 100 of sacrificial support structures which are typical
per cent interconnecting pore network using a three- for most of the other RP/RM technologies. This effect
dimensional fibre-deposition RM technique for can be further increased by using a thixotrope
engineering of articular cartilage. The technique medium [99]. Moreover, in the presence of a tem-
enabled the production of desired scaffold character- perature-controlled plotting medium, the solidifi-
istics by accurately controlling the deposition of cation of the material during plotting into the
molten copolymer fibres from a pressure-driven medium can be caused by precipitation, phase trans-
syringe onto a computer-controlled x–y–z table. The ition, or chemical reaction.
pressure-driven syringe unit contained thermo- The low-temperature deposition manufacturing
statically controlled heating rods capable of evenly (LDM) process requires the material to be fed in a
conducting heat for uniform heating of the co- slurry form. This material has to be able to perform
polymer fibres. By varying PEGT/PBT composition, in a low-temperature environment below 0 °C. Once
porosity, and pore geometry, three-dimensional this material is deposited onto the surface, it freezes.
deposited scaffolds were produced with a range of Hence, control over the glass transition temperature,
mechanical properties. The equilibrium modulus melting temperature, and freezing temperature plays
and dynamic stiffness ranged between 0.05–2.5 and an important role in the realization of this tech-
0.16–4.33 MPa. These results were similar to native nology.
articular cartilage (0.27 and 4.10 MPa). Further stud-
ies were needed in respect of the effects of scaffold
composition and pore architecture on articular carti- 7 CONCLUSIONS
lage tissue formation.
Cesarano [116] reported the fabrication of In vivo devices have been, and contine to be, fabri-
cated to replace or restore functions of living tissues.hydroxyapatite structures with controlled porosity
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5 Lo, H., Kadiyala, S., Guggino, S. E., and Leong,Currently, a number of conventional techniques are
K. W. Poly (l-lactic acid) foams with cell seedingused for the commercial manufacture of in vivo
and controled release capacity. J. Biomed. Mater.devices. Their limitations for economic customiz-
Res., 1996, 30, 475–484.ation, their geometrical restrictions, both internal
6 Mikos, A. G. and Temenoff, J. S. Formation of
and external, and their constraints of compositional highly porous biodegradable scaffolds for tissue
uniformity restrict the possibilities and application of engineering. EJB Electronic J. Biotechnol., 2000,
in vivo devices. Computer-controlled fabrication via 3(2), 114–119.
layer manufacturing has demonstrated the potential 7 Wake, M. C., Gupta, P. K., and Mikos, A. G. Fabri-
cation of pliable biodegradable polymer foams toproduction of in vivo devices of controlled structure,
engineer soft tissues. Cell Transplantation, 1996,shape, and composition that are not possible by con-
4(4), 465–473.ventional techniques. The need for controlled struc-
8 Vacanti, J. P. and Vacanti, C. The challenge oftures in the restoration and regeneration of tissue
tissue engineering. In Principles of Tissue Engin-has resulted in multiple efforts and techniques to
eering (Eds. R. P. Lanza, R. Langer, and W. L. Chick),
fabricate in vivo devices via layer manufacturing. 1997, pp. 1–6 (Academic Press, Austin, Texas).
Among these techniques, three-dimensional print- 9 Ramakrishna, S., Mayer, J., Wintermantel, E., and
ing, selective laser sintering, and fused deposition Leong, K. W. Biomedical applications of polymer-
modelling have been significantly investigated for composite materials: a review. Composites Sci. and
Technol., 2001, 61(9), 1189–1224.intended use in scaffold-based tissue regeneration
10 Leong, K. F., Cheah, C. M., and Chua, C. K. Solidand drug delivery. However, there are significant
freeform fabrication of three-dimensional scaffoldshurdles to be overcome for the practical and indus-
for engineering replacement tissues and organs.trial realization of these production technologies.
Biomaterials, 2003, 24(13), 2363–2378.The most pertinent of these include material restric- 11 Chen, V. J. and Ma, P. X. Nano-fibrous poly(L-lactic
tions, ancillary processes such as design, and regulat- acid) scaffolds with interconnected spherical
ory approval. There have been, and continue to be, macropores. Biomaterials, 2004, 25(11), 2065–2073.
extensive research efforts conducted worldwide to 12 Khalil, S., Nam, J., and Sun, W. Multi-nozzle
enhance and latterly exploit the capabilities of layer deposition for construction of 3D biopolymer
tissue scaffolds. Rapid Prototyping J., 2005, 11(1),manufacturing and rapid manufacturing for the
9–17.production of future in vivo devices. Among these
13 Paul, J. P. Development of standards for ortho-efforts, the Bioplotter developed by Envisiontech
paedic implants. Proc. IMechE, Part H: J. Engin-shows the true validity of these techniques for pro-
eering in Medicine, 1997, 211(H1), 119–126.
ducing in vivo products. Looking towards the future, 14 Hench, L. L. Bioceramics: from concept to clinic.
layer and rapid manufacturing hold great potential J. Am. Ceram. Soc., 1991, 74(7), 1487–1510.
in the fabrication of in vivo devices for a variety of 15 Marti, A. Inert bioceramics for medical appli-
applications including solid implants, porous scaf- cations. Int. J. Care Injured, 2000, 31, 33–36.
folds, and drug delivery devices. However, any future 16 Wang, M. Developing bioactive composite mate-
rials for tissue replacement. Biomaterials, 2003,developments should be based on biomaterial re-
24(13), 2413–2422.quirements driven by tissue engineering. Moreover,
17 Davis, J. R. Overview of biomaterials and their usesuccess and continual investigation is reliant on the
in medical devices. In Handbook of Materials forsuccess and adoption of tissue engineering.
Medical Devices, 2003, pp. 1–11 (ASM Inter-
national).
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